Scholars Central

EditorialPublished 10 Jan 2018

Current Status of Gadolinium Retention in the Brain

Authors: Bakhour D, Saade C

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Gadolinium (Gd3+) based contrast agents previously demonstrated safe administration and were associated with minimal events of adverse reactions until NSF and gadolinium deposits were found in the brain. Gadolinium is a paramagnetic earth lanthanoid element with a ferromagnetic property that is suitable for intravenous administration. Recently, a series of studies raised their concern over the higher risk of developing NSF when administering nonionic linear agents such as gadodiamide and gadoversetamide

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical & Experimental Radiology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Radiology
  • SubjectRadiology & Imaging
  • BylineArticles whose byline prints “Bakhour D”
  • BylineArticles whose byline prints “Saade C”